Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | RO7502175 |
Trade Name | |
Synonyms | RO-7502175|RO 7502175 |
Drug Descriptions |
RO7502175 is an afucosylated antibody targeting CCR8, which induces depletion of CCR8+ T-regulatory cells from the tumor microenvironment, potentially resulting in enhanced antitumor activity (PMID: 38486310). |
DrugClasses | CCR8 Antibody 9 |
CAS Registry Number | NA |
NCIT ID | C205681 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Atezolizumab + RO7502175 | Atezolizumab RO7502175 | 0 | 1 |
RO7502175 | RO7502175 | 0 | 1 |